At
June 30, 2025 and 2024, the Company excluded the outstanding securities summarized below, which entitle the holders thereof to acquire
shares of common stock, from its calculation of earnings per share, as their effect would have been anti-dilutive.
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share
| |
2025 | | |
2024 | |
| |
June 30, | |
| |
2025 | | |
2024 | |
| |
| | |
| |
Series A Convertible Preferred Stock | |
| — | | |
| 72,917 | |
Common stock warrants | |
| 1,275,758 | | |
| 808,365 | |
Common stock options | |
| 744,726 | | |
| 605,348 | |
Total | |
| 2,020,484 | | |
| 1,486,630 | |
|